Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Nov 17 - Nov 22
Absolute contraindications: Active malignancy IGF-1 is mitogenic and promotes cell growth Pregnancy Disruption of the hypothalamic-pituitary axis by injury, tumor, or surgery Hypersensitivity to tesamorelin or mannitol (an excipient in the formulation) A qualified metabolic provider will screen for all of these before initiating therapy
No, IV Therapy does not hurt
Synergistic Benefits The blend of CJC-1295 (no DAC) and Ipamorelin offers several research advantages: Enhanced GH Release: Dual mechanism activation produces more substantial growth hormone pulses than either compound alone
The neuropsychiatric cluster that emerged - centered on anhedonia, anxiety, and insomnia - was not a predictable outcome
Tamoxifen, an estrogen blocker, is effective in treating recent-onset and tender gynecomastia (after stopping or switching spironolactone) when administered at doses of 1020 mg twice daily
US$ 29.67
US$ 23.40
US$ 28.55
US$ 26.17
